Send us Feedback

Salix Pharmaceuticals (SLXP)
Analysis
Data
Financials
No Sales Breakout Data.
Balance Sheet    (USD)
Annual | Quarterly
QUARTER ENDING older 30-SEP
2008		 31-DEC
2008		 31-MAR
2009		 30-JUN
2009		 30-SEP
2009		 newer
Cash & Equivalents 122M 120M 83.5M 86.0M 69.1M
Short Term Investments 0 0 0 0 0
Accounts Receivable 40.7M 40.5M 54.1M 53.4M 75.5M
Inventories 23.1M 17.3M 21.7M 19.6M 22.3M
Pre-paid Expenses 8.74M 8.29M 10.2M 8.72M 9.63M
Deferred Tax Assets 0 0 0 0 0
Other Current Assets 0 0 0 0 0
Total Current Assets 194M 186M 169M 168M 177M
Property, Plant & Equipment 5.30M 4.85M 5.32M 5.15M 5.43M
Goodwill & Intangibles 184M 192M 190M 187M 192M
Other Long-term Assets 20.3M 18.0M 17.2M 17.1M 16.9M
Total Long-Term Assets 226M 215M 212M 209M 214M
Total Assets 421M 401M 382M 377M 391M
Accounts Payable 9.02M 10.1M 10.5M 14.9M 15.8M
Accrued Expenses 0 0 0 0 0
Short Term Debt 869K 849K 866K 864K 840K
Other Current Liabilities 34.5M 34.0M 25.2M 25.7M 27.4M
Total Current Liabilities 64.8M 72.4M 65.3M 73.6M 89.2M
Long Term Debt 75.0M 75.0M 60.4M 61.0M 61.6M
Capital Lease Obligations 821K 2.90M 2.79M 2.61M 2.46M
Deferred Income Tax 0 0 0 0 0
Other Long-term Liabilities 20.6M 0 0 0 0
Total Long-term Liabilities 96.4M 77.9M 63.2M 63.6M 64.1M
Minority Interest 0 0 0 0 0
Total Liabilities 161M 150M 128M 137M 153M
Preferred Stock 0 0 0 0 0
Common Par 48K 48K 48K 48K 49K
Additional Paid-In Capital 401M 403M 419M 421M 426M
Retained Earnings -141M -152M -166M -182M -189M
Treasury Stock 0 0 0 0 0
Other Equity 0 0 0 0 0
Total Shareholder's Equity 260M 251M 253M 240M 237M
 
 
 
 
 
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki